Subspecialties: Page 131

CurveBeam AI gets 'breakthrough device' designation for OssView software

By AuntMinnie.com staff writers

The U.S. Food and Drug Administration has granted CurveBeam AI's OssView bone fragility assessment software breakthrough device designation.

September 11, 2022

PSMA-PET makes a difference for high-risk prostate cancer patients

By Will Morton

Prostate-specific membrane antigen (PSMA)-PET imaging with a gallium-68 PSMA-11 radiopharmaceutical may save a significant number of prostate cancer patients from surgery, according to authors of a research letter published September 12 in JAMA Network Open.

September 11, 2022

Is scientific fraud rife in nuclear medicine journals?

By Will Morton

Scientific fraud may be a problem in nuclear medicine research journals, says a group in the Netherlands that conducted a recent global survey on the issue. Results were published September 8 in the Journal of Nuclear Medicine.

September 11, 2022

Insurance coverage for prostate MRI is inconsistent across the U.S.

By Kate Madden Yee

Insurance coverage for prostate MRI is inconsistent across the U.S., which may contribute to unequal access to the technology for patients, according to a study published September 7 in the American Journal of Roentgenology.

September 8, 2022

Interest in nuclear medicine research dips among residents

By Will Morton

Nuclear medicine's best bet to attract more physicians to the field may be to get its hooks into residents interested in recent clinical advances, according to a study published September 1 in Academic Radiology.

September 8, 2022

CT shows lung problems persist up to a year after COVID-19

By Kate Madden Yee

CT shows that more than a third of people who have contracted COVID-19 may experience persistent lung problems up to a year after recovery, a condition commonly known as long COVID, a group of South Korean investigators has found.

September 8, 2022

Qynapse collaborates with University of Miami on brain study

By AuntMinnie.com staff writers

Artificial intelligence neuroimaging technology firm Qynapse is collaborating with researchers at the University of Miami to explore the effects of COVID-19 on vascular contributions to cognitive impairment and dementia.

September 7, 2022

Materialise launches AI software in China

By AuntMinnie.com staff writers

Materialise has launched its Mimics Enlight 3D artificial intelligence (AI) software in China in partnerships with Zealise Medical and Fluidda.

September 7, 2022

AI bests rads for predicting pancreatic cancer metastasis

By Kate Madden Yee

Chinese researchers have found that artificial intelligence (AI) outperforms not only radiologists but also clinical and radiomic models when it comes to predicting lymph node metastasis in patients with pancreatic ductal adenocarcinoma cancer.

September 7, 2022

Do we need a better way to evaluate cardiac screening?

By Frederic W. Grannis Jr.

Although coronary artery disease is the number one cause of death in the U.S. today, there is no accepted screening test for the disease. Dr. Frederic Grannis wonders whether recent research studies are asking the right question.

September 7, 2022

MIDRC launches AI COVID-19 challenge

By AuntMinnie.com staff writers

The Medical Imaging and Data Resource Center's (MIDRC) COVIDx artificial intelligence (AI) challenge is officially underway.

September 6, 2022

Brainomix, Bridge Biotherapeutics partner

By AuntMinnie.com staff writers

U.K. artificial intelligence software developer Brainomix and Bridge Biotherapeutics have partnered to deliver imaging biomarker analysis in a study that is testing Bridge's autotaxin inhibitor BBT-877 as a treatment for idiopathic pulmonary fibrosis.

September 6, 2022

Previous Page

Page 131 of 1553

Next Page